Slow And Steady Wins The Race With Regencell Bioscience
NEWS AND UPDATES Slow And Steady Wins The Race With Regencell Bioscience Summary Regencell Bioscience is an early-stage bioscience company focused on the research, development, and commercialization of Traditional Chinese Medicine. Regencell Chairman and CEO, Yat-Gai Au recently purchased more than $5.9 million in RGC shares. Majority shareholders of Regencell are […]
Our CEO Shares His Vision, Insights And Aims To Change The Way Patients Are Treated
NEWS AND UPDATES Our CEO Shares His Vision, Insights And Aims To Change The Way Patients Are Treated Market sentiment has been relatively bearish over the last couple of months, as the ongoing health crisis and political tension has pushed market and economic performance to the brink of a looming recession. On top of this, […]
The Top Performing IPO Stock Of 2021
NEWS AND UPDATES The Top Performing IPO Stock Of 2021 2021 was the busiest year for deals since 2000, with a record-breaking IPO rush of 1,035 listings in the US, with the biotech and healthcare sectors leading the way, accounting for 36% of all IPO activity. While […]
RGC CEO Figuratively Putting His Money Where His Mouth Is
NEWS AND UPDATES RGC CEO Figuratively Putting His Money Where His Mouth Is Investors have faced challenging and volatile markets so far in 2022 as they sort through issues of inflation, supply chain disruption, continued covid issues, rising interest rates, and the disruption of the war in Ukraine. The S&P 500 has come close to […]
Regencell Featured on ValueWalk
NEWS AND UPDATES Game-Stop Or Game-On? Regencell Has It All And Twice More Regencell Bioscience Limited’s (NASDAQ:RGC) stock is an undiscovered short squeeze potential. The short volume ratio has similar pattern as that of GameStop Corp. (NYSE:GME), whereby both averaged over 40% in the past year. In fact, RGC is more heavily shorted than GME as some […]
Regencell Featured on Benzinga
NEWS AND UPDATES Traders May Keep Hunting For Another “Squeezable” Stock Like Gamestop CEO Elon Musk recently claimed that Microsoft Corp. Co-Founder Bill Gates has a multibillion-dollar short position against his company. Musk suggested he doesn’t trust Gates and his stated commitment to addressing climate change, given his bets against Tesla. “Too often, sophisticated hedge funds have used […]
Second Investigational Study Of our COV19™ Replicates Results Of Earlier Trial In Eliminating COVID-19 Symptoms
NEWS AND UPDATES Second Investigational Study Of our COV19™ Replicates Results Of Earlier Trial In Eliminating COVID-19 Symptoms News Report by Beth Senko, CFA (Senior Analyst) In March 2020, Regencell’s strategic partner and TCM practitioner, Mr. Sik-Kee Au, modified his proprietary cold and flu TCM formula for use in COVID-19 patients. The TCM practitioner subsequently […]
Additional EARTH Efficacy Trial Results Corroborating Effectiveness of our Investigational Liquid-Formula RGC-COV19™
NEWS AND UPDATES Additional EARTH Efficacy Trial Results Corroborating Effectiveness of our Investigational Liquid-Formula RGC-COV19™ Regencell Bioscience Announces Additional EARTH Efficacy Trial Results Corroborating Effectiveness of its Investigational Liquid-Formula RGC-COV19TM in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-Day Treatment Period Results of EARTH efficacy trial EARTH Efficacy Trials Period of trial 30 […]
